Peripheral T-cell lymphoma, NEC, intrapelvic nodes is a subtype of non-Hodgkin lymphoma characterized by the proliferation of malignant T-cells in the intrapelvic lymph nodes. This condition is clinically significant due to its aggressive nature and potential for systemic involvement. Accurate coding with ICD-10 Code C84.46 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex malignancy.
ICD-10 Code C84.46 represents Peripheral T-cell lymphoma, NEC, specifically affecting the intrapelvic lymph nodes. This code is utilized when documenting cases of T-cell lymphoma that do not fall under more specific classifications. It is crucial for accurate clinical documentation and billing, particularly when managing patients with this aggressive form of lymphoma.
Peripheral T-cell lymphoma, NEC, intrapelvic nodes is caused by the malignant transformation of T-lymphocytes, leading to lymphadenopathy and potential systemic symptoms. The condition requires prompt medical attention due to its aggressive behavior and risk of complications. Early diagnosis and treatment are critical for improving patient outcomes.
ICD-10 Code C84.46 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code C84.46 connects subjective patient reports and objective clinical findings to a formal diagnosis of Peripheral T-cell lymphoma, NEC, intrapelvic nodes. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment of Peripheral T-cell lymphoma, NEC, intrapelvic nodes is critical due to its aggressive nature. Hospitalization may be necessary for intensive management.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.46 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 96415 | Chemotherapy administration, intravenous, each additional substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C84.46 for Peripheral T-cell lymphoma, NEC, intrapelvic nodes
What are the common symptoms of Peripheral T-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, weight loss, and fatigue. Patients may also experience abdominal discomfort if lymph nodes in the pelvic region are affected.
How is Peripheral T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of malignant T-cells.
What treatment options are available for Peripheral T-cell lymphoma?
Treatment often includes chemotherapy, radiation therapy, and supportive care to manage symptoms and complications. The specific regimen depends on the patient's overall health and disease stage.
Is Peripheral T-cell lymphoma curable?
The prognosis for Peripheral T-cell lymphoma varies based on factors such as the specific subtype, stage at diagnosis, and response to treatment. Some patients may achieve remission, while others may require ongoing management.
Clinical Notes
SOAP notes
DAP notes
AI medical notes